FOLD — Amicus Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Amicus Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	482	294	286	250	294
Net Total Accounts Receivable
Net Total Receivables	52.7	66.2	87.6	101	115
Total Inventory
Prepaid Expenses
Total Current Assets	597	424	483	505	676
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	63.1	60.3	58	51.7	48.2
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	905	724	778	785	950
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	146	139	168	149	238
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	598	601	618	591	676
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	307	123	160	194	274
Total Liabilities & Shareholders' Equity	905	724	778	785	950
Total Common Shares Outstanding